MS
RDUS

Maven Securities’s Radius Health, Inc. RDUS Stock Holding History

Maven Securities’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-935
Closed -$36K – 66
2016
Q4 		$36K Buy
+935
New +$44.5K 0.03% 37

Other funds holding RDUS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Maven Securities's RDUS Position: Q1 2017 in Review

Maven Securities sold out of Radius Health, Inc. (RDUS) in Q1 2017, closing a stake of 935 shares — an estimated $36K sold.

Maven Securities first reported a position in RDUS in Q4 2016 and held it in 1 quarter. The position peaked at $36K in Q4 2016. 152 funds tracked by Wall St. Rank hold RDUS as of Q1 2017.

  • Maven Securities reported no remaining Radius Health, Inc. position as of Q1 2017 after selling out during the quarter.
  • Maven Securities sold 935 Radius Health, Inc. shares in Q1 2017, an estimated $36K.
  • Maven Securities first reported a position in Radius Health, Inc. in Q4 2016 and held it in 1 quarter.
  • Maven Securities's Radius Health, Inc. position peaked at $36K in Q4 2016.
  • 152 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2017.

Based on Maven Securities's 13F filing for Q1 2017, filed 15 May 2017.